Growth Metrics

Orthopediatrics (KIDS) Liabilities and Shareholders Equity (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Liabilities and Shareholders Equity for 10 consecutive years, with $508.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 7.49% to $508.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 billion, a 7.95% increase, with the full-year FY2025 number at $508.6 million, up 7.49% from a year prior.
  • Liabilities and Shareholders Equity was $508.6 million for Q4 2025 at Orthopediatrics, up from $493.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $508.6 million in Q4 2025 to a low of $301.0 million in Q1 2022.
  • A 5-year average of $412.9 million and a median of $431.6 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Biggest YoY gain for Liabilities and Shareholders Equity was 79.88% in 2021; the steepest drop was 6.34% in 2021.
  • Orthopediatrics' Liabilities and Shareholders Equity stood at $304.3 million in 2021, then skyrocketed by 40.57% to $427.7 million in 2022, then grew by 2.58% to $438.7 million in 2023, then increased by 7.86% to $473.2 million in 2024, then grew by 7.49% to $508.6 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Liabilities and Shareholders Equity are $508.6 million (Q4 2025), $493.5 million (Q3 2025), and $503.6 million (Q2 2025).